What is the treatment for chronic prostatitis?

Patients with chronic prostatitis are more difficult to treat, and they must use some comprehensive treatment methods to achieve some improvement. Even psychological treatment is necessary, because prostatitis can cause some psychological damage to patients, and may even cause inferiority complex. So let us take a look at the treatment methods for chronic prostatitis.

1. General treatment Health education, psychological and behavioral counseling have a positive effect. Patients should abstain from alcohol, spicy food, hold urine, sit for long periods of time, keep warm, and strengthen physical exercise.

2. Drug treatment The most commonly used drugs are antibiotics, α-receptor blockers, herbal preparations and non-steroidal anti-inflammatory analgesics. Other drugs also have varying degrees of effectiveness in relieving symptoms.

(1) Antibiotics: Currently, in the clinical practice of treating prostatitis, the most commonly used first-line drug is antibiotics, but only about 5% of patients with chronic prostatitis have clear bacterial infection.

Chronic bacterial prostatitis: antibiotics are selected based on bacterial culture results and the ability of the drug to penetrate the prostate. After prostatitis is confirmed, the course of antibiotic treatment is 4 to 6 weeks, during which the patient should undergo periodic efficacy evaluation. Intraprostatic injection of antibiotics is not recommended.

Chronic nonbacterial prostatitis: Antibiotic treatment is mostly empirical treatment, and the theoretical basis is to speculate that certain pathogens that are negative in routine culture cause the occurrence of this type of inflammation. Therefore, it is recommended to take oral antibiotics such as fluoroquinolone for 2 to 4 weeks, and then decide whether to continue antibiotic treatment based on the feedback of the efficacy. Only when the clinical symptoms are indeed alleviated, it is recommended to continue the use of antibiotics. The recommended total course of treatment is 4 to 6 weeks.

(2) α-receptor blockers: α-receptor blockers can relax the smooth muscles of the prostate and bladder and improve lower urinary tract symptoms and pain, thus becoming a basic drug for the treatment of type II/type III prostatitis.

Different α-receptor blockers can be selected according to the patient's condition. The recommended α-receptor blockers are: doxazosin, naftopidil, tamsulosin and terazosin. The results of controlled studies show that the above drugs have different degrees of improvement on patients' urination symptoms, pain and quality of life index.

(3) Plant preparations: Plant preparations are increasingly valued for their therapeutic effects on type II and type III prostatitis and are recommended as therapeutic drugs. Plant preparations mainly refer to pollen preparations and plant extracts, which have a wide range of pharmacological effects, such as non-specific anti-inflammatory, anti-edema, and promoting bladder detrusor contraction and urethral smooth muscle relaxation. Recommended plant preparations include: Pusitai, Sabah palm and its extracts. Due to the large number of varieties, the usage and dosage must be determined according to the patient's specific condition, and the course of treatment is usually in months. Adverse reactions are relatively small.

(4) Nonsteroidal anti-inflammatory analgesics: Nonsteroidal anti-inflammatory analgesics are empirical medications for the treatment of symptoms associated with type III prostatitis. Their main purpose is to relieve pain and discomfort.

(5) M-receptor blockers: M-receptor blockers (such as tolterodine) can be used to treat prostatitis patients who have symptoms such as urinary urgency, frequent urination and nocturia but no urinary tract obstruction.

The above article tells us in detail the treatment methods of chronic prostatitis. So while cooperating with the treatment, patients should still choose some diets that are more beneficial to their bodies, such as millet or black beans, which are good for their stomachs.